Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kameyama A, Yazawa K, Kaibara M et al. Run-down of the cardiac Ca2+ channel: Characterization and restoration of channel activity by cytoplasmic factors. Pflugers Arch 1997; 433:547–556.
Kameyama M, Kameyama A, Takano E et al. Run-down of the cardiac L-type Ca2+ channel: Partial restoration of channel activity in cell-free patches by calpastatin. Pflugers Arch 1998b; 435:344–349.
Becq F. Ionic channel rundown in excised membrane patches. Biochim Biophys Acta 1996; 1286:53–63.
Romanin C, Grosswagen P, Schindler H. Calpastatin and nucleotides stabilize cardiac calcium channel activity in excised patches. Pflugers Arch 1991; 418:86–92.
Seydl K, Karlsson JO, Dominik A et al. Action of calpastatin in prevention of cardiac L-type Ca2+ channel run-down cannot be mimicked by synthetic calpain inhibitors. Pflugers Arch 1995; 429:503–510.
Fenwick EM, Marty A, Neher E. Sodium and calcium channels in bovine chromaffin cells. J Physiol 1982; 331:599–635.
Nilius B, Hess P, Lansman JB et al. A novel type of cardiac calcium channel in ventricular cells. Nature 1985; 316:443–446.
Perez-Reyes E, Cribbs LL, Daud A et al. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 1998; 391:896–900.
Hockberger PE, Nam SC. High-voltage-activated calcium current in developing neurons is insensitive to nifedipine. Pflugers Arch 1994; 426:402–411.
Tombaugh GC, Somjen GG. Differential sensitivity to intracellular pH among high-and low-thresh old Ca2+ currents in isolated rat CA1 neurons. J Neurophysiol 1997; 77:639–653.
Martini M, Rossi ML, Rubbini G et al. Calcium currents in hair cells isolated from semicircular canals of the frog. Biophys J 2000; 78:1240–1254.
Morita H, Cousins H, Onoue H, et al. Predominant distribution of nifedipine-insensitive, high voltage-activated Ca2+ channels in the terminal mesenteric artery of guinea pig. Circ Res 1999; 85:596–605.
Kameyama M, Kameyama A, Nakayama T et al. Tissue extract recovers cardiac calcium channels from ‘run-down’. Pflugers Arch 1988; 412:328–330.
Kameyama M, Kameyama A, Kaibara M et al. Mechanisms of rundown of cardiac calcium channels. In: Yamada K, Shibata S, eds. Recent Advances on Calcium Channels and Antagonists. New York: Pergamon Press, 1990:3–10.
Kostyuk PG. Intracellular perfusion of nerve cells and its effects on membrane currents. Physiol 1984; Rev 64:435–454.
Armstrong D, Eckert R Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci USA 1987; 84:2518–2522.
Ono K, Fozzard HA. Phosphorylation restores activity of L-type calcium channels after rundown in inside-out patches from rabbit cardiac cells. J Physiol 1992; 454:673–688.
Costantin JL, Qin N, Waxham MN, et al. Complete reversal of run-down in rabbit cardiac Ca2+ channels by patch-cramming in Xenopus oocytes; Partial reversal by protein kinase A. Pflugers Arch 1999; 437:888–894.
Chad JE, Eckert R. An enzymatic mechanism for calcium current inactivation in dialysed Helix neurones. J Physiol 1986; 378:31–51.
Belles B, Hescheler J, Trautwein W et al. A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes. Pflugers Arch 1988; 412:554–556.
Levitan IB. Phosphorylation of ion channels. J Membr Biol 1985; 87:177–190.
Yazawa K, Kameyama A, Yasui K et al. ATP regulates cardiac Ca2+ channel activity via a mechanism independent of protein phosphorylation. Pflugers Arch 1997; 433:557–562.
Elhamdani A, Bossu JL, Feltz A. ADP exerts a protective effect against rundown of the Ca2+ current in bovine chromaffin cells. Pflugers Arch 1995; 430:401–409.
De Jongh KS, Murphy BJ, Colvin AA et al. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3′,5′-cyclic monophosphate-dependent protein kinase. Biochemistry 1996; 35:10392–10402.
Leach RN, Brickley K, Norman RI. Cyclic AMP-dependent protein kinase phosphorylates residues in the C-terminal domain of the cardiac L-type calcium channel alpha1 subunit. Biochim Biophys Acta 1996; 1281:205–212.
Mitterdorfer J, Froschmayr M, Grabner M et al. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry 1996; 35:9400–9406.
Perets T, Blumenstein Y, Shistik E et al. A potential site of functional modulation by protein kinase A in the cardiac Ca2+ channel alpha 1C subunit. FEBS Lett 1996; 384:189–192.
Sperelakis N. Regulation of ion channels by phosphorylation. In: Sperelakis N, ed. Cell Physiology Source Book. 2nd ed. San Diego: Academic Press, 1998:499–509.
Kameyama A, Hao LY, Takano E et al. Characterization and partial purification of the cytoplasmic factor that maintains cardiac Ca2+ channel activity. Pflugers Arch 1998a; 435:338–343.
Croall DE, DeMartino GN. Calcium-activated neutral protease (calpain) system: Structure, function, and regulation. Physiol Rev 1991; 71:813–847.
Hao LY, Kameyama A, Kameyama M. A cytoplasmic factor, calpastatin and ATP together reverse run-down of Ca2+ channel activity in guinea-pig heart. J Physiol 1999; 514 (Pt 3):687–699.
Ma H, Yang HQ, Takano E et al. Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains. J Biochem (Tokyo) 1993; 113:591–599.
Wang KK. Developing selective inhibitors of calpain. Trends Pharmacol Sci 1990; 11:139–142.
Mehdi S. Cell-penetrating inhibitors of calpain. Trends Biochem Sci 1991;16:150–153.
Emori Y, Kawasaki H, Imajoh S et al. Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci USA 1987; 84:3590–3594.
Imajoh S, Kawasaki H, Emori Y et al. Calcium-activated neutral protease inhibitor from rabbit erythrocytes lacks the N-terminal region of the liver inhibitor but retains three inhibitory units. Biochem Biophys Res Commun 1987; 146:630–637.
Hao LY, Kameyama A, Kuroki S et al. Calpastatin domain L is involved in the regulation of L-type Ca2+ channels in guinea pig cardiac myocytes. Biochem Biophys Res Commun 2000; 279:756–761.
Walker D, De Waard M. Subunit interaction sites in voltage-dependent Ca2+ channels: Role in channel function. Trends Neurosci 1998; 21:148–154.
Isom LL, De Jongh KS, Catterall WA. Auxiliary subunits of voltage-gated ion channels. Neuron 1994;12:1183–1194.
Striessnig J. Pharmacology, structure and function of cardiac L-type Ca2+ channels. Cell Physiol Biochem 1999; 9:242–269.
Soldatov NM. Molecular diversity of L-type Ca2+ channel transcripts in human fibroblasts. Proc Natl Acad Sci USA 1992; 89:4628–4632.
Soldatov NM. Genomic structure of human L-type Ca2+ channel. Genomics 1994; 22:77–87.
Kepplinger KJ, Forstner G, Kahr H et al. Molecular determinant for run-down of L-type Ca2+ channels localized in the carboxyl terminus of the 1C subunit. J Physiol 2000; 529 (Pt 1):119–130.
Soldatov NM, Oz M, O’Brien KA et al. Molecular determinants of L-type Ca2+ channel inactivation. Segment exchange analysis of the carboxyl-terminal cytoplasmic motif encoded by exons 40–42 of the human alpha1C subunit gene. J Biol Chem 1998; 273:957–963.
Soldatov NM, Zuhlke RD, Bouron A et al. Molecular structures involved in L-type calcium channel inactivation. Role of the carboxyl-terminal region encoded by exons 40–42 in alpha 1C subunit in the kinetics and Ca2+ dependence of inactivation. J Biol Chem 1997; 272:3560–3566.
Gao T, Yatani A, Dell’Acqua ML et al. cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997; 19:185–196.
Lorca T, Galas S, Fesquet D et al. Degradation of the proto-oncogene product p39mos is not necessary for cyclin proteolysis and exit from meiotic metaphase: requirement for a Ca2+-calmodulin dependent event. Embo J 1991; 10:2087–2093.
Josephson IR, Varadi G. The beta subunit increases Ca2+ currents and gating charge movements of human cardiac L-type Ca2+ channels. Biophys J 1996; 70:1285–1293.
Schmid R, Seydl K, Baumgartner W et al. Trypsin increases availability and open probability of cardiac L-type Ca2+ channels without affecting inactivation induced by Ca2+. Biophys J 1995; 69:1847–1857.
Peterson BZ, DeMaria CD, Adelman JP et al. Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of L-type calcium channels. Neuron 1999; 22:549–558.
Qin N, Olcese R, Bransby M et al. Ca2+-induced inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc Natl Acad Sci USA 1999; 96:2435–2438.
Zuhlke RD, Pitt GS, Deisseroth K et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999; 399:159–162.
Takano E, Murachi T. Purification and some properties of human erythrocyte calpastatin. J Biochem (Tokyo) 1982; 92:2021–2028.
Takano E, Kitahara A, Sasaki T et al. Two different molecular species of pig calpastatin. Structural and functional relationship between 107 kDa and 68 kDa molecules. Biochem J 1986; 235:97–102.
Takano E, Maki M, Mori H et al. Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis. Biochemistry 1988; 27:1964–1972.
Maki M, Takano E, Mori H et al. Repetitive region of calpastatin is a functional unit of the proteinase inhibitor. Biochem Biophys Res Commun 1987; 143:300–308.
Yakel JL. Inactivation of the Ba2+ current in dissociated Helix neurons: Voltage dependence and the role of phosphorylation. Plugers Arch 1992; 420:470–478.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Eurekah.com and Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Kepplinger, K.J.F., Romanin, C. (2005). The Run-Down Phenomenon of Ca2+ Channels. In: Voltage-Gated Calcium Channels. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-27526-6_14
Download citation
DOI: https://doi.org/10.1007/0-387-27526-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47840-6
Online ISBN: 978-0-387-27526-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)